Multimodal Artificial Intelligence for Detecting the Psychological State of Cancer Patients
AIPSY
2 other identifiers
observational
1,500
1 country
1
Brief Summary
Artificial intelligence (AI) technology is expected to assist clinical doctors in promptly identifying cancer patients at risk of developing psychological issues and to develop preemptive management plans, thereby enhancing their quality of life. Computer vision technology can directly capture and extract subtle changes in skin color from facial images in videos, assess heart rate using signal processing algorithms, and also extract facial expressions to evaluate psychological conditions through facial expression change signal processing algorithms. The accuracy rate can exceed 88%. By leveraging the capabilities of computer vision technology, it can accurately capture subtle movements and expressions of the human body, thereby understanding the internal psychological state and obtaining relevant psychological information
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Mar 2021
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 1, 2021
CompletedFirst Submitted
Initial submission to the registry
March 25, 2026
CompletedFirst Posted
Study publicly available on registry
August 7, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2028
ExpectedStudy Completion
Last participant's last visit for all outcomes
December 31, 2028
August 7, 2026
August 1, 2026
7.8 years
March 25, 2026
August 6, 2026
Conditions
Outcome Measures
Primary Outcomes (1)
Area Under the Receiver Operating Characteristic Curve (AUC) of the Multimodal Machine Learning Model for Anxiety and Depression Screening
The AUC quantifies the overall discriminative ability of the final multimodal machine learning model to distinguish between patients with positive vs. negative anxiety/depression status. The AUC will be calculated on an independent test set that is strictly separated from the training and validation sets and will not be used in any model training or hyperparameter tuning.
Data collected at two time points: 1 day pre-operatively and at ≤7 days post-operatively or at discharge, whichever came first
Eligibility Criteria
Patients with cancers such as liver cancer, thyroid cancer and lung cancer et al. The demographic and clinical characteristics of tumor patients were collected and included, including age, gender, educational background, monthly income, marital status, ECOG score, liver function stage, Barcelona stage, recurrence frequency, lesion information, biochemical indicators, etc
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Chinese PLA Hospital
Beijing, China
MeSH Terms
Conditions
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator, Chief Physician
Study Record Dates
First Submitted
March 25, 2026
First Posted
August 7, 2026
Study Start
March 1, 2021
Primary Completion (Estimated)
December 31, 2028
Study Completion (Estimated)
December 31, 2028
Last Updated
August 7, 2026
Record last verified: 2026-08